Dr. Bratman is Scientist at Princess Margaret Cancer Centre Research Institute and Assistant Professor of Radiation Oncology & Medical Biophysics at the University of Toronto. He received his MD and PhD from Columbia University in 2009 followed by postdoctoral research and clinical training at Stanford Cancer Institute. Since joining The Princess Margaret in 2014, Dr. Bratman has served as Staff Radiation Oncologist within the Wharton Head and Neck Centre and has led basic, translational, and clinical research studies on head and neck cancer and circulating biomarkers.
Dr. Bratman's primary research focus is on improving outcomes for patients with head and neck cancer and other cancers through optimized detection and personalized treatments. His laboratory is currently developing and validating blood-based biomarkers for detecting and monitoring the presence of cancer.
Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy.
Cancer. 2017 Jun 13;:
Morphologic and topographic radiologic features of human papillomavirus-related and unrelated oropharyngeal carcinoma.
Head Neck. 2017 Jun 05;:
The Cisplatin Total Dose and Concomitant Radiation in Locoregionally Advanced Head and Neck Cancer: Any Recent Evidence for Dose Efficacy?
Curr Treat Options Oncol. 2017 Jul;18(7):39
Lancet Oncol. 2017 May;18(5):e238
Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates.
Nat Commun. 2017 May 11;8:15086
J Natl Cancer Inst. 2017 Apr 01;109(4):
Re-evaluation of Ipsilateral Radiation for T1-T2N0-N2b Tonsil Carcinoma at the Princess Margaret Hospital in the Human Papillomavirus Era, 25 Years Later.
Int J Radiat Oncol Biol Phys. 2017 Jan 09;:
Exploring the Impact of Human Papillomavirus Status, Comorbidity, Polypharmacy, and Treatment Intensity on Outcome of Elderly Oropharyngeal Cancer Patients Treated With Radiation Therapy With or Without Chemotherapy.
Int J Radiat Oncol Biol Phys. 2016 Nov 27;:
Biology and patterns of response to EGFR-inhibition in squamous cell cancers of the lung and head & neck.
Cancer Treat Rev. 2017 Jan 17;54:43-57
Distant Metastases Following Postoperative Intensity-Modulated Radiotherapy for Oral Cavity Squamous Cell Carcinoma.
JAMA Otolaryngol Head Neck Surg. 2016 Dec 29;:
Scientist, Princess Margaret Cancer Centre
Assistant Professor, Department of Medical Biophysics, University of Toronto
Assistant Professor, Department of Radiation Oncology, University of Toronto